FDA Cleared
Introducing Tixel-i:
an eye opening relief
A 2-minute treatment for Dry Eye Disease with no expression needed. Best in class results and longer lasting relief with proven safety.
Talk to a specialistMajor Reduction in Symptoms
OSDI Score
Patients reported major reduction of their symptoms that continue after treatments.
OSDI scores range from 0-100, with lower scores indicating fewer symptoms. Scores above 33 indicate severe dry eye disease.
Improved Tear Retention
TBUT seconds
Subjective improvement during treatments.
Objective improvement continued after all treatments were completed.
TBUT measures tear film stability. Higher values indicate better tear film stability. A TBUT of 10 seconds or more is generally considered normal.
Industry-first capabilities for Dry Eye Disease
Effective
Patients report significant relief for months after treatment
Fast
Three quick two-minute treatments. Two weeks apart
Simple
Incredibly easy to use, light to carry, fits in every clinic
Proven
Thoroughly researched and studied across the globe
Versatile
Effective on all skin types
Cost Effective
Zero disposables and fast patient turn-around
Disclaimer: Dry Eye indication is currently under review and has not yet received CE marking
Experts trust it,
patients swear by it
